PRKD1 and colonic neoplasm: Treatment of colon cancer cells with NaBT activates PKD that induces the activity of SphK2 and stimulates its translocation from the nucleus into the cytosol where SphK2 accumulates and inhibits NaBT-induced apoptosis.